Closing the gap between access to and adoption of type 1 diabetes (T1D) therapies is a mission priority for Breakthrough T1D. Breakthrough T1D Chief Medical Officer Dr. Thomas Danne spoke with us about the role our Medical Affairs team plays in helping ensure that emerging T1D therapies—like the ones we’re learning about here at ADA—are adopted by healthcare providers sooner. Learn more about the work our Medical Affairs team does here: https://bit.ly/45uxVcA | Breakthrough T1D

15 reactions | For his role in the landmark discovery that molecular "chaperones" play a major role in protein folding, F. Ulrich Hartl was awarded the 2020 Breakthrough Prize in Life Sciences. See his full acceptance speech here https://youtu.be/ft6wh1ude7s?si=9MMZ5kK4M9rH8E-5&t=301 | Breakthrough | Facebook